Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri-Columbia, Columbia, Missouri, USA.
Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri-Columbia, Columbia, Missouri, USA.
World Neurosurg. 2020 Sep;141:e935-e940. doi: 10.1016/j.wneu.2020.06.089. Epub 2020 Jun 17.
We performed this analysis to identify the rates, predictors, and associated outcomes of unexpected neurosurgical evacuation in a multicenter randomized clinical trial, Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) 2.
The ATACH 2 trial determined the efficacy of antihypertensive treatment in patients with spontaneous supratentorial intracerebral hemorrhages (ICHs) with a Glasgow Coma Scale (GCS) score of ≥5 and intraparenchymal hematoma volume of <60 cm on initial computed tomographic scan. We determined the proportion of ICH patients requiring unanticipated surgical evacuation and identified baseline factors associated with evacuation.
Among the 992 subjects analyzed, 44 (4.4%) subjects required unanticipated surgical evacuation of hematoma. The proportion of subjects with initial GCS score of 13 or less was significantly higher among those who required surgical evacuation (43.2% vs. 26.8%, P < 0.001). In the logistics regression analysis, hematoma volume ≥18 cm (odds ratio, 4.3; 95% confidence interval, 2.1-8.8) and right-sided hematoma (odds ratio, 2.8; 95% confidence interval, 1.3-5.9) were significantly associated with surgical evacuation. Age, location, GCS score strata, and allocated treatment (intensive vs. standard systolic blood pressure reduction) were not associated with surgical evacuation. Among the 44 patients who underwent surgical evacuation, death or disability at 3 months postrandomization was seen in 32 (73%) of 44 subjects.
In the large cohort of ATACH 2 subjects with good grade ICH, the rates of unanticipated surgical evacuation were low and were associated with relatively high rates of death or disability at 3 months.
我们进行了这项分析,以确定多中心随机临床试验中意外神经外科清除的发生率、预测因素和相关结局,即抗高血压治疗急性脑出血(ATACH)2。
ATACH 2 试验确定了降压治疗在格拉斯哥昏迷量表(GCS)评分≥5 且初始计算机断层扫描显示颅内血肿量<60cm 的自发性幕上脑出血(ICH)患者中的疗效。我们确定了需要意外手术清除血肿的 ICH 患者的比例,并确定了与清除相关的基线因素。
在分析的 992 名受试者中,有 44 名(4.4%)受试者需要意外清除血肿。需要手术清除的患者中初始 GCS 评分≤13 的比例明显更高(43.2%比 26.8%,P<0.001)。在逻辑回归分析中,血肿量≥18cm(优势比,4.3;95%置信区间,2.1-8.8)和右侧血肿(优势比,2.8;95%置信区间,1.3-5.9)与手术清除明显相关。年龄、位置、GCS 评分分层和分配的治疗(强化与标准收缩压降低)与手术清除无关。在接受手术清除的 44 名患者中,3 个月后随机死亡或残疾的有 32 名(73%)。
在 ATACH 2 中具有良好 ICH 分级的大量受试者中,意外手术清除的比例较低,与 3 个月时较高的死亡率或残疾率相关。